Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer.
Brueckmann
M
M
First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. martina.brueckmann@med.ma.uni-heidelberg.de
Borggrefe
M
M
D000818:Animals; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C / Q000276:immunology*; D003110:Colonic Neoplasms / Q000276:immunology / Q000628:therapy*; D004195:Disease Models, Animal; D007167:Immunotherapy / Q000379:methods*; D008565:Membrane Proteins / Q000276:immunology*; D009362:Neoplasm Metastasis
D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C; D008565:Membrane Proteins